RE:RE:CLOVIS is next on the FDA Calendar
Francois, yes I'm sure our share price will jump with FDA approvals as it often does on very positive news. It's the volume.... We need volume to sustain an increase in share price. I believe PLI will be a success story but it may be a rougher ride than I ever could have imagined . GLTA! I'm NOT selling.